000 01035 a2200313 4500
005 20250517003604.0
264 0 _c20150804
008 201508s 0 0 eng d
022 _a1750-7448
024 7 _a10.2217/imt.14.73
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWard, Frank J
245 0 0 _aTargeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy?
_h[electronic resource]
260 _bImmunotherapy
_c2014
300 _a1073-84 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlternative Splicing
650 0 4 _aAnimals
650 0 4 _aCTLA-4 Antigen
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aProtein Isoforms
_ximmunology
700 1 _aDahal, Lekh N
700 1 _aKhanolkar, Rahul C
700 1 _aShankar, Sucharita P
700 1 _aBarker, Robert N
773 0 _tImmunotherapy
_gvol. 6
_gno. 10
_gp. 1073-84
856 4 0 _uhttps://doi.org/10.2217/imt.14.73
_zAvailable from publisher's website
999 _c24383949
_d24383949